artrix, Author at 维梧资本|专注医疗健康领域的投资公司

Vivo Leads a $32mm Series A Financing in HistoWiz
Gallery
Vivo Leads a $32mm Series A Financing in HistoWiz

全部新闻, 美国投资项目

Vivo Leads a $32mm Series A Financing in HistoWiz

Vivo Leads a $32mm Series A Financing in HistoWizartrix2021-10-20T21:56:59-07:00

We are thrilled to reinvest in InBrace, one of our portfolio companies’ $102M, series D financing.
Gallery
We are thrilled to reinvest in InBrace, one of our portfolio companies’ $102M, series D financing.

全部新闻, 美国投资项目

We are thrilled to reinvest in InBrace, one of our portfolio companies’ $102M, series D financing.

We are thrilled to reinvest in InBrace, one of our portfolio companies’ $102M, series D financing.artrix2021-09-09T20:16:22-07:00

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders
Gallery
Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

全部新闻, 维梧新闻

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disordersartrix2021-08-28T22:52:55-07:00

Portfolio Company, Ascendis Pharma, received FDA approval for SKYTROFA®
Gallery
Portfolio Company, Ascendis Pharma, received FDA approval for SKYTROFA®

全部新闻, 美国投资项目

Portfolio Company, Ascendis Pharma, received FDA approval for SKYTROFA®

Portfolio Company, Ascendis Pharma, received FDA approval for SKYTROFA®artrix2021-08-30T21:49:11-07:00

Portfolio Company, Kadmon received FDA approval for REZUROCK
Gallery
Portfolio Company, Kadmon received FDA approval for REZUROCK

全部新闻, 美国投资项目

Portfolio Company, Kadmon received FDA approval for REZUROCK

Portfolio Company, Kadmon received FDA approval for REZUROCKartrix2021-07-18T21:03:52-07:00

Vivo is Excited to Announce the IPO of Portfolio Company, Sera Prognostics!
Gallery
Vivo is Excited to Announce the IPO of Portfolio Company, Sera Prognostics!

全部新闻, 美国投资项目

Vivo is Excited to Announce the IPO of Portfolio Company, Sera Prognostics!

Vivo is Excited to Announce the IPO of Portfolio Company, Sera Prognostics!artrix2021-07-18T21:02:34-07:00

World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Use
Gallery
World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Use

全部新闻, 美国投资项目

World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Use

World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Useartrix2021-06-01T20:29:23-07:00

Vivo Capital invests $50mm in Scientia Vascular
Gallery
Vivo Capital invests $50mm in Scientia Vascular

全部新闻, 美国投资项目

Vivo Capital invests $50mm in Scientia Vascular

Vivo Capital invests $50mm in Scientia Vascularartrix2021-06-01T20:28:12-07:00

Vivo leads Esco’s $200 million Series A
Gallery
Vivo leads Esco’s $200 million Series A

全部新闻, 美国投资项目

Vivo leads Esco’s $200 million Series A

Vivo leads Esco’s $200 million Series Aartrix2021-05-27T13:48:46-07:00

Vivo invests in a Rgenta
Gallery
Vivo invests in a Rgenta

全部新闻, 美国投资项目

Vivo invests in a Rgenta

Vivo invests in a Rgentaartrix2021-05-27T13:49:49-07:00

关于 artrix